Skip to main content
Caplight Logo









DNAe

DNAe

Private
LondonHealthcare & Life Scienceshttps://www.dnae.com/

Last Round

Grant

Sep 30, 2016

Total Funding Raised

$113.9M

Company Overview

DNAe is a biotechnology company that develops a semiconductor-based, point-of-need next-generation sequencing platform for rapid infectious disease and oncology diagnostics.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Precision Medicine, Semiconductors, Biotech Equipment

Business Model

B2B

Customer Profile

Hardware Sales, Usage-Based SaaS, Government Contracts

AI Layer

Non-AI

Keywords

point-of-need diagnosticsnext-generation sequencingNGSbloodstream infection diagnosticsantimicrobial resistance testingAMRbedside diagnosticssemiconductor sequencingcartridge-based diagnosticsrapid pathogen identificationsample-to-reportmolecular diagnosticslab-on-a-chipclinical sequencingSTAT laboratory equipment

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

DNAe Comparables

Compare DNAe with similar companies based on industry and business-model similarity.

DNAe comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
GenomeKey
81%
HelixBind
80%
Scanogen Inc.
78%

DNAe Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantSep 30, 2016
DebtNov 2, 2015
Corporate FundingJan 15, 2015
Early FundingApr 27, 2014

Key People

Founding team and executive leadership

Sam Reed

CEO President

Executive Team

Patrick Stephansen

CFO

Executive Team

DNAe Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 16, 2026

    Monthly visitors increased 31% MoM, from 6.2K to 8.2K.

  • Mar 3, 2026

    Monthly visitors grew 108% MoM, from 3K to 6.2K.

DNAe Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

DNAe Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about DNAe's valuation, stock price, and market status.

Firmographic Details

HeadquartersLondon
Employee Range176
Year Founded2003
Last FundingSep 30, 2016

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?